Influence of vascular access type on outcome measures in patients on maintenance hemodialysis

Deepa H Chand1, Boon Wee Teo, Richard A Fatica

  • 1Department of Pediatric Nephrology and Hypertension, Akron Children's Hospital, Akron, Ohio 44308, USA. dchand@chmca.org

Insights

Patients on hemodialysis using central venous catheters (CVC) show poorer outcomes than those with arteriovenous fistulae (AVF) or grafts (AVG). This highlights the need to prioritize AVF or adjust CVC care for better results in end-stage renal disease (ESRD) patients.

Area of Science:

  • Nephrology
  • Vascular Access
  • Renal Replacement Therapy

Background:

  • End-stage renal disease (ESRD) patients often require hemodialysis.
  • Vascular access type (arteriovenous fistula (AVF), arteriovenous graft (AVG), or central venous catheter (CVC)) significantly impacts patient outcomes.
  • Previous studies suggest poorer outcomes for patients using CVC compared to AVF or AVG.

Purpose of the Study:

  • To compare clinical measures of dialysis adequacy, anemia management, and nutritional/inflammatory status among prevalent hemodialysis patients based on vascular access type.
  • To determine if current clinical practice guidelines adequately address potential outcome disparities related to vascular access.

Main Methods:

  • Analysis of data from The Renal Network Data System for 12,501 prevalent hemodialysis patients in 2003.
  • Univariate analysis of variance used to compare Kt/V, Urea Reduction Ratio (URR), albumin, hemoglobin (Hb), and recombinant human erythropoietin (EPO) dose across access types (AVF, AVG, CVC).
  • Statistical adjustments made for pertinent confounding factors.

Main Results:

  • Central venous catheter (CVC) use was observed in 23% of patients, contrasted with 36% for AVF and 41% for AVG.
  • Patients dialyzed via CVC demonstrated significantly lower mean URR, Kt/V, and albumin concentrations (p < 0.001) compared to AVF and AVG users.
  • While serum hemoglobin levels were similar across groups (p = 0.416), CVC patients required higher doses of EPO (p < 0.001).

Conclusions:

  • Despite established practice guidelines, hemodialysis patients utilizing CVC exhibit inferior clinical outcomes compared to those with AVF or AVG.
  • Findings underscore the importance of prioritizing AVF use or implementing appropriate adjustments for CVC patients to achieve comparable outcomes.
  • Further research is recommended to identify and address the barriers contributing to these disparities in CVC patient care.
Abstract

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...